BEWARE...SOME DAYS ARE NOT VERY PRETTY. I GET CRABBY LIKE NORMAL PEOPLE DO. AND I DO SPEAK MY MIND.
DO NOT READ IF YOU ARE SENSITIVE TO TRUE, REAL, EVERYDAY FEELINGS LIKE MINE.(But I think you would enjoy it)
DON'T FORGET...FREEDOM OF SPEECH !
(Why do people keep believing this crap? And its sad that there will be so many to believe it.)
( She's NOT the first you bunch of idiots !!!)
Good Morning America finally deletes tweet praising Justice Jackson as 'the first Black Supreme Court justice'
Ketanji Brown Jackson was sworn into the Supreme Court on Thursday
On
today’s episode, Joey Jones is 'Outnumbered' as the Supreme Court rules
to end remain in Mexico policy. Plus, Biden trying to sell 2024 to
Democratic Party.
ABC’s "Good Morning America" Twitter account made a major historic mistake when reporting on Ketanji Brown Jackson’s swearing-in ceremony as a Supreme Court justice.
On
Thursday, Jackson was officially sworn in as a justice of the Supreme
Court following Justice Stephen Breyer’s retirement. GMA covered the
moment she was welcomed onto the court by Justice John Roberts, but
their Twitter account claimed that Jackson was "the first Black Supreme
Court justice."
"Ketanji Brown Jackson is sworn in as the first Black Supreme Court justice in U.S. history," GMA tweeted at 1:46 p.m.
GMA's tweet originally read, "Ketanji Brown Jackson is sworn in as
the first Black Supreme Court justice in U.S. history."
(Twitter)
Jackson
is officially the third Black person to sit on the Supreme Court. The
first Black Supreme Court justice was Thurgood Marshall who served on
the court from 1967 to 1991. The second Black justice is Clarence Thomas, Marshall’s successor in 1991, who currently sits on the bench.
GMA made the same mistake on their YouTube account.
"Ketanji Brown Jackson sworn in as first Black Supreme Court justice in US history," the video headline read.
GMA's original YouTube video was titled, "Ketanji Brown Jackson
sworn in as first Black Supreme Court justice in US history"
(Youtube)
The
tweet was deleted almost five hours later, and the YouTube video was
corrected shortly afterward that. A new tweet issued a correction.
"CORRECTION:
Video shows Ketanji Brown Jackson sworn in as the first Black female
Supreme Court justice in U.S. history. A previous tweet erroneously
stated Jackson is the first Black Supreme Court justice," GMA wrote.
Before the tweet was deleted, however, several Twitter users called out the misstep by GMA.
"They
didn’t vote for Biden, so they ‘ain’t black’ in Democrat/media world
view," Ron DeSantis spokesperson Christina Pushaw tweeted.
Townhall.com web editor Rebecca Downs tweeted, "Really curious if the social media person still has a job…"
Author Max Abrahms joked, "Did Clarence Thomas cease being black because of his politics?"
Newsbusters
Managing editor Curtis Houck wrote, "D*mn you all are so superficial
with mindless segments on Disney cruise ships, giving away free
vacations, and doing ‘Steals and Deals’ that you can't be bothered to
know basic facts!"
Media Research Center's Nick Fondacaro noted,
"Even if ABC's intention was to spite Justice Clarence Thomas, they
still overlooked Justice Thurgood Marshall."
Back
in April, during Jackson’s original Senate Judiciary hearing, Politico
made a similar mistake, claiming in a tweet and article that Jackson was
the "first Black Supreme Court justice."
Judge Ketanji Brown Jackson, accompanied by Vice President Kamala
Harris, speaks during an event on the South Lawn of the White House in
Washington, Friday, April 8, 2022, celebrating the confirmation of
Jackson as the first Black woman to reach the Supreme Court. (AP
Photo/Andrew Harnik)
Although
Jackson is not the first Black Supreme Court justice to sit on the
bench, she is the first Black woman to serve as a justice. She will
begin her first term in October.
Lindsay
Kornick is an associate editor for Fox News Digital. Story tips can be
sent to lindsay.kornick@fox.com and on Twitter: @lmkornick.
For
the last 18 months, the original COVID-19 vaccines — first as a
two-dose series, then as boosters — have done an extraordinary job
shielding us from illness, hospitalization and death. Globally, they saved nearly 20 million lives in 2021 alone. Even today, unvaccinated Americans are twice as likely as vaccinated Americans to test positive for COVID — and six times as likely to die from the disease.
But viruses evolve, and vaccines should too.
That
was the big-picture takeaway from a pivotal meeting this week of the
U.S. Food and Drug Administration’s expert advisory panel. The question
before them was simple: Ahead of an expected winter surge, should
vaccine manufacturers tweak their forthcoming booster shots to target
Omicron — the ultra-infectious variant that has spent the last seven
months surging throughout the world in one form or another — or should
they stick with the tried-and-true 2020 recipe?
The panel voted 19-2 on Tuesday in favor of Omicron boosters. The question now, however, is which version of Omicron the next round of shots should target.
For
anyone who hasn’t been paying attention, the Omicron strain that
triggered last winter’s massive COVID wave (BA.1) is now extinct. In
March, it was supplanted by the even more transmissible BA.2 … which was
supplanted in May by the even more transmissible BA.2.12.1 … which is
now being supplanted by the (you guessed it) even more transmissible
BA.4 and BA.5.
Experts say BA.5 is the one to worry about: “The
worst version of the virus that we’ve seen,” as Dr. Eric Topol, the
founder of Scripps Research Translational Institute, recently put it. Together, the closely related BA.4 and BA.5 now account for the majority of new U.S. COVID cases, according to the latest data from the Centers for Disease Control and Prevention — but BA.5 (36.6%) is spreading a lot faster than BA.4 (15.7%). By early July, it will be the dominant strain in the U.S.
That’s troublesome for several reasons. To our immune system, the distance from BA.1 to heavily mutated BA.4 and BA.5 is “far greater,” Topol writes, than the distance from the original BA.1virus
to previous blockbuster variants such as Alpha and Delta — which makes
them harder to recognize and respond to. According to the latest
research, that could mean:
More symptoms. BA.4 and BA.5 are also better at replicating in lung cells than BA.2 — a shift that could mean, according to one experimental model, that they’re more “pathogenic” as well (i.e., more likely to make you sick).
More resistance to treatments. At the same time, BA.4 and BA.5 appear to be 20-fold more resistant than BA.2 to Evusheld — an important monoclonal antibody treatment that has been providing preemptive protection for immunocompromised people.
None
of this will set the U.S. back to square one. Despite elevated case
levels, there are now fewer U.S. COVID patients in intensive care units
than there were during previous phases of the pandemic, and the national
death rate (about 300-400 per day) is near the all-time low. Acquired
immunity, multiple rounds of vaccination and improved treatment options
are helping — a lot.
It could also endanger vulnerable Americans in the months ahead.
In late April, BA.5 hit Portugal; by June, more Portuguese people were dying of COVID each day
than during the country’s winter Omicron peak. To be sure, Portugal has
a larger senior population (23%) than the U.S. (16%), but not by much.
And the vaccination rate there is 87%, compared to just 67% in America.
Portugal’s booster rate, meanwhile, is nearly twice as high as ours. Infection and hospitalization rates are now rising across much of the rest of Europe as well.
At
Tuesday’s FDA advisory meeting, Justin Lessler, an epidemiologist at
the University of North Carolina at Chapel Hill, presented a series of
projections about how the virus could affect the U.S. in the months
ahead. The most optimistic scenario? About 95,000 new deaths between
March 2022 and March 2023. The most pessimistic? More than 200,000.
So
given that BA.5 — which, again, is outcompeting its cousin BA.4 — will
soon be everywhere, it seems logical that the next version of the
vaccine should be tailored to fight it.
Yet that hasn’t
necessarily been the plan. Both Pfizer and Moderna have already launched
clinical trials for redesigned fall boosters … but those boosters are
optimized to counter the now-nonexistent BA.1 rather than the
soon-to-be-dominant BA.5. According to data presented Tuesday by Pfizer,
their existing BA.1 booster generated a significantly lower level of neutralizing antibodies against BA.4 and BA.5 than against BA.1.
Yet in mice, at least, a booster containing BA.4 and BA.5 produced a higher neutralizing response to all Omicron variants (including BA.4 and BA.5) than the original vaccine.
Despite
concerns about “scant” data about whether bivalent boosters (equal
parts original strain and Omicron) work better than monovalent boosters
(100% Omicron), and about whether it’s worth waiting for Novavax’s
promising non-mRNA vaccine to hit the market, the panel mostly agreed
that BA.4/BA.5 boosters make sense. The FDA is leaning that way as well.
Pfizer said it was “prepared” to deliver the new boosters by the first
week of October; Moderna, by the last week of October or early November —
“assuming no clinical data requirements.”
That means no human
trials — just animal trials and laboratory tests. That might sound scary
to some, but regulators already use the same accelerated process to
update the flu vaccine each year — and there is no mechanism by which
minor mRNA tweaks will make revised Pfizer and Moderna shots any less
safe than the billions of doses administered so far worldwide.
Otherwise, the U.S. will miss its fall-winter deadline, and the
fast-evolving virus will continue to outrun the vaccines.
The FDA itself will decide “very rapidly” what to recommend; manufacturers will follow their lead.
In
the future, chasing variants may not prove to be the most effective or
efficient approach to COVID vaccination. As Topol put it, “by the time a
BA.5 vaccine booster is potentially available, who knows what … the
predominant strain” will be? That’s why it was welcome news Wednesday
when Pfizer and BioNTech announced that they plan to “start tests on
humans of next-generation shots that protect against a wide variety of
coronaviruses in the second half of the year,” according to a Reuters report.
These
include “T-cell-enhancing shots, designed to primarily protect against
severe disease if the virus becomes more dangerous,” and
“pan-coronavirus shots that protect against the broader family of
viruses and its mutations.” Nasal vaccines meant to stop infection
before it starts are promising as well.
But
those are all longer-term propositions. This year, at least, a BA.5
booster is probably our best bet to minimize infection, illness and
death during another likely winter surge.
“I fully expect further
evolution to occur in the coming months, but that this evolution will
most likely be on top of BA.4/BA.5 — and so [it] shouldn’t dissuade
vaccine updates,” virologist Trevor Bedford of the Fred Hutchinson
Cancer Research Center in Seattle wrote earlier this week.
“I believe that the decision making process can be boiled down to: of
vaccine compositions that can be manufactured in time for fall
distribution, which do we expect to generate the highest [protection]
against BA.4/BA.5?”
Montreal-raised standup comedian Nick Nemeroff died suddenly on Monday at the age of 32, his family announced in a Twitter post.
“It is with profound sadness that we announce the sudden passing of our beloved brother Nick Nemeroff,” a statement on his Twitter account read.
“Nick’s dedication to standup was formidable, and produced amazing
results. He drew acclaim in Canada and the US, becoming both a ‘comic’s
comic’ and a hit with crowds who were enamored by his unique cadence,
labyrinthine deadpan, and fresh take on misdirection-driven comedy,” the
post added. “If Nick was on a comedy show, he was guaranteed to leave
with new fans. And he deserved to, because comedy was, in many ways, his
life.”
“Endlessly sweet, supportive of others, humble about his many skills
and achievements, Nick lived his life doing what he loved, and that is
how he will be remembered. RIP Nick. We love you,” the statement
concluded.
His cause of death has not been revealed yet. His manager, Morgan
Flood of Grand Wave Entertainment, told CBC News that he has no
information yet on the cause of death but that Nick “died in his sleep.”
Funeral arrangements are yet to be announced.
Back in 2021, Nick posted a tweet about having a side effect following his Covid-19 vaccination.
“Ok so I got the vaccine and it did have a side effect…the area the
needle went into (if I had to describe it I’d say like, on the top part
of my upper arm. If that makes sense?) hurt a bit after,” he wrote.
“Seems ok now but honestly do NOT recommend getting it & wish I
could take it back.”
Nick posted another video attacking the Pfizer Covid vaccine. In the
video, Nick can be heard saying he will not get the booster shot.
“I will not get the third shot. I will not. Pfizer me once, no shame.
Pfizer me twice, shame on COVID. Pfizer me three times, shame on you.
You want me to get a third shot? What’s next? A fifth shot? No, thank
you,” Nick argued.
DEBUNKED! Jan. 6
Committee “Surprise” Witness GETS CAUGHT – US Secret Service Sources
DENY Trump Tried to Grab Steering Wheel — ARE WILLING TO TESTIFY!
On Tuesday, Liz Cheney and the sham Jan. 6 committee brought in Mark Meadows staffer Cassidy Hutchinson as a “surprise witness.”
Young Cassidy testified that “she was told” that as then-President
Donald Trump was being driven back to the White House after the Jan. 6
rally that he demanded to be taken to the Capitol and tried to grab the steering wheel from a Secret Service agent.
Hutchinson said Trump got into “the beast” after his speech at the
Ellipse on January 6 with the belief that he would be driven to the
Capitol.
According to Hutchinson, who received this information from Tony
Ornato, the Assistant Director for the Secret Service, Trump grew angry
after he was informed that he was being driven back to the West Wing.
The fake news media ran with Cassidy’s explosive testimony.
Hutchinson said Trump traveled in “The Beast” over to the Ellipse that day.
But Trump was in the Presidential SUV not “The Beast.”
NOW THIS—
The Secret Service denied the report and the agents are ready and willing to testify.
NBC News White House Correspondent Peter Alexander tweeted–
US Secret Service statement:
“U.S. Secret Service has been cooperating with the Select Committee since its inception in spring 2021, and will continue to do so, including by responding on the record to the Committee regarding the new allegations surfaced in today’s testimony."
According to reports, agents are prepared to go before
Congress to flatly contradict an aide's claim that Donald Trump lunged
at a driver inside a presidential car and demanded that he be taken to
the Capitol on Jan. 6, 2021, as the historic breach there was unfolding.
[Full Story]